Bliss GVS Pharma Ltd. commissions phase 1 of new facility at Palghar East.

Bliss GVS Pharma Ltd. has completed the commissioning & qualification of Phase-I for its new state of the art multi-product facility situated at Palghar East in Maharashtra. This is the largest manufacturing unit of the Company in terms of planned production capacity when completed. It is equipped with state of the art process equipment & utilities with a large part of the manufacturing process automated for enhanced levels of productivity, efficiency & compliance while reducing manual intervention.

The unit is spread on an overall area of about 200,000 sq. ft. and is intended to further augment the production capacities for the Company. "We have a robust pipeline of formulations ready at our R&D unit for WHO Pre-qualification along with US and EU Markets for Tech-Transfer & Scale Up for this unit and we foresee a healthy business growth from our new Unit. In line with our commitment towards sustainability, a significant portion of the energy requirement of this facility will be met by captive solar power generation units." said Gagan Harsh Sharma, VP-Strategy & Business Development, Bliss GVS Pharma Limited.

The Company has received necessary permissions for the facility from the relevant authorities to commence tech-transfer / validation activities.

EQUITYBULLS